Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating reslizumab in adults with moderate-to-severe asthma has completed, with results posted in 2016, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• reslizumab (reslizumab)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Eosinophilic Asthma | Phase 3 | Status: COMPLETED | Results posted: 2016-06-27